Positive sentiment for pharma stocks lifts Cipla 4%; UBS maintains buy
NewsNews / News 7 years ago 595 Views comments
"Cipla is our top pick in the sector given high branded generic exposure," UBS said.
Related Posts
News / News 7 years ago 595 Views comments
Comments